Abstract The objective of this study was to prospectively assess the prevalence, predictors and prognostic
Introduction
Microalbuminuria is a known marker of vascular permeability and endothelial dysfunction, and has been found to be predictive of outcome in a wide variety of chronic and acute conditions such as neoplastic disease [1, 2] , surgery [3] , acute pancreatitis [4] and trauma [5] .
In acute setting, microalbuminuria has been shown to be a useful tool to predict illness severity and outcome in critically ill adult patients admitted to an intensive care unit (ICU) [6] [7] [8] , but in these studies acute cardiac patients are scarcely or not represented. Gopal et al. [6] report that microalbuminuria predicts ICU mortality and inotrope requirement, as well as or better than APACHE II and SOFA scores in a mixed population (including about 10% cardiac surgery patients). Similar results are reported by Abid et al. [7] in a small subset of 40 medical patients (three patients with cardiorespiratory arrest), and by Thorevska et al. [9] in 104 critically ill patients (sepsis was present in the 43.3% of all population).
The aim of the present investigation was therefore to prospectively assess the prevalence, predictors and prognostic significance of microalbuminuria in a large cohort of consecutive acute cardiac patients, admitted to our intensive cardiac care unit (ICCU).
Methods
We prospectively enrolled all 888 patients admitted to our ICCU from 1 January 2008 to 30 June 2009. Exclusion criteria were as follows: pre-existing chronic renal failure (60 patients), no urine output on the first day of admission, on renal replacement therapy, or overtly bloody urine (13 patients) [9] . Our study population was 815 patients.
Microalbuminuria was measured on the first day of admission (in the overnight urine collection), and was defined as ranging from 20 to 200 lg/min [10] . On ICCU admission, after PCI, in a fasting blood sample the following parameters were measured: glucose (g/l), troponin I (Tn I, ng/ml), uric acid (mg/dl) [11] , NT-pro brain natriuretic peptide (NT-BNP) (pg/ml) [12] , leukocytes count (910 3 /ll), fibrinogen (mg/dl), erythrocyte sedimentation rate (ESR), lactate, C-reactive protein (C-RP, mg/dl). Creatinine (mg/dl) was also measured in order to calculate glomerular filtration rate (ml/min/1.73 m 2 ) [13] . Glucose values were measured three times a day and peak glucose was considered. In patients with STEMI and UA/NSTEMI Tn I was measured three times a day and peak Tn I was reported [11, 12] .
Transthoracic 2-dimensional echocardiography was performed on ICCU admission in order to measure left ventricular ejection fraction (LVEF).
In-ICCU mortality was the end point of outcome in our study.
Statistical analysis
Data were processed by means of SPSS 13.0 statistical package (SPSS Inc., Chicago, IL, USA). A two-tailed p value \0.05 was considered statistically significant. Data are reported as frequencies (percentages) and medians [95% Confidence Interval (CI)] and analyzed by means of v 2 (or Fisher's exact text, when appropriate) and MannWhitney U test. By means of Spearman's rho the correlations between the presence of microalbuminuria, LVEF, C-reactive protein, admission glycemia and NT-pro BNP were assessed. A backward stepwise logistic regression analysis was conducted in order to identify the variables correlated to microalbuminuria and in-ICCU death. In the logistic models, candidate variables were chosen as those that were significantly different at univariable analysis, or were clinically relevant. Backward procedure (probability for entry 0.05; probability for removal 0.10) was repeated until all variables in the model reached statistical significance. For each model, calibration was assessed by means of a Hosmer-Lemeshow goodness of fit test; pseudo R 2 were also assessed. Receiver operating characteristic (ROC) curves were constructed for microalbuminuria and in-ICCU death.
Results
Our series comprises the following subgroups according to admission diagnosis, as follows:
1. ST elevation myocardial infarction [14] : in our hospital, in Florence, the reperfusion strategy of STEMI patients is represented by primary PCI [12] . The patients are first evaluated by the Medical Emergency System in the pre-hospital setting, and then directly admitted to the catheterization laboratory or transferred to it after a rapid stabilization in the emergency department (ED). After primary PCI, they are admitted to our ICCU. Table 1 depicts the clinical characteristics of the 815 patients included in the study. Men are more prevalent (67.4%), and hypertension is present in more than half of the patients (64.3%). Acute coronary syndrome (that is STEMI and UA/NSTEMI) is the most frequent admission diagnosis accounting for 71.4%. In-ICCU mortality rate was 4% (33/815).
Among patients with estimated glomuerular filtration rate (eGFR) C60 ml/min/1.73 m 2 (who accounted for 84.4%), microalbuminuria is detectable in the 35%, while in patients with eGFR \60 ml/min/1.73 m 2 it is found in 62.4%. Table 2 The following variables are independently associated with the development of microalbuminuria (when adjusted for age, hypertension, diabetes, eGFR, C-RP and EF): NTpro BNP (100 pg/ml step: OR 1.004; 95% CI 1.002-1.007; p = 0.002); glycemia (1 g/dl step: OR 1.686; 95% CI 1.201 to 2.366; p = 0.003). Nagelkerke R 2 0.16; HosmerLemeshow goodness of fit 6.329, p = 0.610.
At backward regression analysis, the following variables are independent predictors for in-ICCU mortality: Admission eGFR (1 ml/min/1.73m2 step) (OR 0.973; 95% CI 0.959-0.988; p \ 0.001); LVEF (1% step) (OR 0.944; 95% CI 0.914-0.975; p \ 0.001); Microalbuminuria (1 lg/min step) (OR 1.017; 95% CI 1.010-1.024; p \ 0.001). Nagelkerke R 2 0.34; Hosmer-Lemeshow goodness of fit 11.626, p = 0.169.
Based on the ROC curve for the entire population, the optimum microalbuminuria threshold for in-ICCU death should be 20 lg/min. This threshold would have yielded a sensitivity of 91% (95% CI 76-98%) and a specificity of 60% (05% CI 56-63%). The positive predictive value is 8.7%, while the negative predictive value is 99.4%. The corresponding RR for microalbuminuria [20 mg/dl is 13.6 (95% CI 4.5-41.7; p \ 0.001).
Discussion
The main finding of the present investigation is that in a large cohort of consecutive acute cardiac patients, microalbuminuria on admission shows a high prevalence (being detectable in the 39.3%), and it is an independent predictor of in-ICCU mortality.
Microalbuminuria is recognized as a strong and independent indicator of increased cardiovascular risk among subjects with and without diabetes [17] , its presence substantially increases the cardiovascular risk, and it is an independent predictor of ischemic heart disease in a population-based cohort [18] . In chronic heart failure, elevated albumin excretion is a powerful prognostic marker for allcause mortality, independent of diabetes, hypertension, or renal function [19] .
Our series includes mainly patients with acute coronary syndromes who undergo mechanical revascularization (accounting for 71.4% of the entire population), but available evidence of the prognostic significance of microalbuminuria in these patients is so far controversial. In patients with acute myocardial infarction (AMI) [20] [21] [22] microalbuminuria has been reported to occur early, yielding prognostic information about in-hospital mortality additional to that provided by clinical or echocardiographic evaluation of left ventricular function. In non-diabetic patients with AMI [23] , microalbuminuria has been shown to be a predictor not only for mortality but even for morbidity. In hypertensive patients with AMI [24] , the combination between microalbuminuria and hypertension is associated with a higher risk of in-hospital mortality, independent of other possible confounders (such as heart failure). Previous investigations have been performed in heterogeneous populations of patients with hypertension and myocardial infarction, diabetic and non-diabetic, submitted either to thrombolysis or to mechanical revascularization or not revascularized. Conversely, in our paper [25] , in the early phase of 257 STEMI hypertensive patients without previously known diabetes all submitted to mechanical revascularization, microalbuminuria, though a common finding, did not yield prognostic information about in-hospital mortality or complications.
In the present investigation, microalbuminuria shows a strong independent prognostic role for early mortality, independent of the admission diagnosis. This can be probably related to the fact that microalbuminuria is strictly linked to the inflammatory activation (as inferred by C-RP) and glucose values, as a part of the acute stress response. C-RP is a well known prognostic marker in cardiovascular diseases, both in chronic and acute cardiac conditions [26] [27] [28] [29] . In a previous paper [25] performed in hypertensive non-diabetic STEMI patients, microalbuminuria was associated with acute glucose dysmetabolism (as inferred by hyperglycemia and the prevalence of insulin-resistance), thus suggesting that it can be considered as the part of the acute metabolic response to stress.
In our series, microalbuminuria correlates with NT-pro BNP values, which is known as a strong predictor for cardiovascular mortality [30] . Our findings are in agreement with recent investigations performed in humans [31] and in animal models [32] . In Japanese hypertensive patients, a concomitant reduction in BNP and microalbuminuria is observed after therapy [33] , while in hypertensive rats, microalbuminuria is significantly correlated with reductions in cardiac mass and hypertrophy markers (such as BNP), thus suggesting a potential link between microalbuminuria and BNP. In the acute phase of STEMI [10] , NT-pro BNP is related to the extension of myocardial injury (as inferred by peak Tn I), and to inflammatory activation (as indicated by C-RP). It is an independent predictor for early mortality.
The main limitation of the present study is that it comprises unselected patients admitted to our ICCU because of varying diagnoses (from acute coronary syndrome to acute pulmonary embolism). On the other hand, our population including consecutive acute cardiac patients, reflects the ''contemporary clinical practice'' in an ICCU of a tertiary center.
In conclusion, in the acute phase of cardiac patients, microalbuminuria is a common finding and it represents an independent predictor for early mortality. It is strictly linked to the inflammatory activation (as indicated be C-RP) and to acute glucose values, thus suggesting that it is the part of the acute response to stress.
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